Vasotec is the brand name for the drug enalapril, an angiotensin-converting enzyme inhibitor used to treat hypertension and heart failure. It functions by blocking the conversion of angiotensin i to angiotensin ii, thereby reducing vasoconstriction and aldosterone secretion. This leads to vasodilation and decreased blood volume, which lowers arterial pressure and reduces cardiac workload. The medication is absorbed orally, metabolized minimally, and excreted primarily through the kidneys, maintaining steady plasma concentrations. By modulating the renin-angiotensin system, it produces sustained antihypertensive effects without significant immediate impact on heart rate. The overall pharmacological action results in improved endothelial function and decreased remodeling of the heart and vessels.

Vasotec is an angiotensin converting enzyme inhibitor prescribed to manage high blood pressure and heart failure. It works by blocking the enzyme that converts angiotensin i into angiotensin ii, a hormone that causes blood vessels to narrow. This inhibition prevents vasoconstriction and reduces the release of aldosterone, leading to lower blood pressure. The resulting decrease in resistance allows the heart to pump more efficiently. The drug also improves kidney perfusion and helps preserve renal function in certain conditions. Together these actions make Vasotec effective for controlling hypertension and supporting cardiac health.

Dizziness may occur. Loss of taste can appear. Fatigue is possible. Cough may develop. Headache can be noted. A mild rash might be observed.

Vasotec may cause a persistent cough that can be bothersome. It can lead to dizziness or lightheadedness especially when standing up quickly. Some users experience headaches that vary in intensity. Fatigue is reported by many patients during treatment. Nausea or mild stomach discomfort may occur. Blood pressure levels can drop resulting in faintness. Elevated potassium levels are observed in certain cases. Rarely skin rashes or itching may develop.